Evozyne
Mohamed (Sid) Siddeek is a seasoned professional currently serving as Corporate Vice President and Head of NVentures, NVIDIA's Venture Capital Group, since September 2021. In addition to this role, Siddeek is an active investor in multiple companies, including Orbital Materials, Freeform, World Labs, Exa, nTop, EvolutionaryScale, Arsenal Biosciences, Inc., Contextual AI, and PolyAI, all of which began partnerships in 2024. The educational background includes a Bachelor's Degree in Molecular Biochemistry and Biophysics from Yale University, attendance at Harvard Medical School for a joint MD/MS program, an MBA with double majors in Finance and Accounting from The Wharton School, and a year of study in Engineering Sciences at the University of Oxford.
This person is not in any teams
This person is not in any offices
Evozyne
1 followers
Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems. From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world.